Author:
Zhilyaeva T.V.,Kasyanov E.D.,Rukavishnikov G.V.,Piatoikina A.S.,Bavrina A.P.,Kostina O.V.,Zhukova E.S.,Shcherbatyuk T.G.,Mazo G.E.
Funder
Russian Foundation for Basic Research
Subject
Biological Psychiatry,Pharmacology
Reference62 articles.
1. A depression rating scale for schizophrenics;Addington;Schizophr. Res.,1990
2. Evaluation of oxidative stress in biological samples using the Thiobarbituric acid reactive substances assay;Aguilar Diaz De Leon;J. Vis. Exp.,2020
3. In schizophrenia, the effects of the IL-6/IL-23/Th17 Axis on health-related quality of life and disabilities are partly mediated by generalized cognitive decline and the Symptomatome;Al-Musawi;Int. J. Environ. Res. Public Health,2022
4. Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia;Anderson;Prog. Neuro-Psychopharmacol. Biol. Psychiatry,2013
5. Methods for Assessing Free Radical Oxidation and the Body Antioxidant System: Guidelines. Foliant, St-Petersburg;Arutyunyan,2000